相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。O-6-Methylguanine-DNA Methyltransferase (MGMT) Immunohistochemical Expression in Pituitary Corticotroph Adenomas
Fateme Salehi et al.
NEUROSURGERY (2012)
DAMP-mediated autophagy contributes to drug resistance
Liying Liu et al.
AUTOPHAGY (2011)
Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status
Ann I. McCormack et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2011)
MGMT promoter methylation and immunoexpression in aggressive pituitary adenomas and carcinomas
Fateme Salehi et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Pathogenesis of pituitary tumors
Shlomo Melmed
NATURE REVIEWS ENDOCRINOLOGY (2011)
The Nuclear Guanine Nucleotide Exchange Factors Ect2 and Net1 Regulate RhoB-Mediated Cell Death after DNA Damage
Melissa C. Srougi et al.
PLOS ONE (2011)
The Role of Kinesin Family Proteins in Tumorigenesis and Progression
Yue Yu et al.
CANCER (2010)
Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)
Alberto Fernandez et al.
CLINICAL ENDOCRINOLOGY (2010)
Low Immunohistochemical Expression of MGMT in ACTH Secreting Pituitary Tumors of Patients with Nelson Syndrome
Fateme Salehi et al.
ENDOCRINE PATHOLOGY (2010)
Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases
Marco Losa et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Per3, a circadian gene, is required for Chk2 activation in human cells
Jun-Sub Im et al.
FEBS LETTERS (2010)
Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
Zachary M. Bush et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Temozolomide Treatment in Aggressive Pituitary Tumors and Pituitary Carcinomas: A French Multicenter Experience
Gerald Raverot et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Pituitary senescence: The evolving role of Pttg
Vera Chesnokova et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Gene Regulation by Nucleoporins and Links to Cancer
Alwin Koehler et al.
MOLECULAR CELL (2010)
Dealing with DNA damage: Relationships between checkpoint and repair pathways
Daniel O. Warmerdam et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2010)
MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib
Manik Chahal et al.
NEURO-ONCOLOGY (2010)
Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3β-mediated cyclin D1 overexpression
T. Shimura et al.
ONCOGENE (2010)
MGMT immunoexpression in aggressive pituitary adenoma and carcinoma
Queenie Lau et al.
PITUITARY (2010)
The Pathogenesis of Pituitary Tumors
Sylvia L. Asa et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
The pathophysiology of pituitary adenomas
Dorota Dworakowska et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
O6-Methylguanine DNA Methyltransferase Immunoexpression in Nonfunctioning Pituitary Adenomas Are Progressive Tumors Potential Candidates for Temozolomide Treatment?
Georg Widhalm et al.
CANCER (2009)
Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells
Sarah E. Golding et al.
CANCER BIOLOGY & THERAPY (2009)
DNA Repair in Mammalian Cells
T. Nouspikel
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours
Ann I. McCormack et al.
CLINICAL ENDOCRINOLOGY (2009)
High incidence of low O6-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease
Akira Takeshita et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Treatment of Nelson's syndrome with temozolomide
V. J. Moyes et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Pituitary gland and β-catenin signaling: from ontogeny to oncogenesis
Maria Gueorguiev et al.
PITUITARY (2009)
p21CiP1 restrains pituitary tumor growth
Vera Chesnokova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
O6-Methylguanine-DNA-methyltransferase promoter demethylation is involved in basic fibroblast growth factor-induced resistance against temozolomide in human melanoma cells
Dennis Fontijn et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Novel mechanism whereby nuclear factor κB mediates DNA damage repair through regulation of O6-methylguanine-DNA-methyltransferase
Iris Lavon et al.
CANCER RESEARCH (2007)
Temozolomide in the treatment of an invasive prolactinoma resistant to dopamine agonists
Lisa M. Neff et al.
PITUITARY (2007)
GSK-3β-regulated interaction of BICD with dynein is involved in microtubule anchorage at centrosome
Katsumi Fumoto et al.
EMBO JOURNAL (2006)
High prevalence of pituitary adenomas: A cross-sectional study in the province of Liege, Belgium
Adrian F. Daly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Antitumour effects of temozolomide in a man with a large, invasive prolactin-producing pituitary neoplasm
Luis V. Syro et al.
CLINICAL ENDOCRINOLOGY (2006)
Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study
Mariagiovanna Filippella et al.
CLINICAL ENDOCRINOLOGY (2006)
Long-term response of pituitary carcinoma to temozolomide - Report of two cases
Camilo E. Fadul et al.
JOURNAL OF NEUROSURGERY (2006)
Combined effect of proteasome and calpain inhibition on cisplatin-resistant human melanoma cells
Izabela Mlynarczuk-Bialy et al.
CANCER RESEARCH (2006)
Damage of zinc fingers in DNA repair proteins, a novel molecular mechanism in carcinogenesis
A Witkiewicz-Kucharczyk et al.
TOXICOLOGY LETTERS (2006)
Engineering zinc finger protein transcription factors: The therapeutic relevance of switching endogenous gene expression on or off at command
WM Gommans et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Proteomic analysis of human O6-methylguanine-DNA methyltransferase by affinity chromatography and tandem mass spectrometry
SK Niture et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Magnetic resonance imaging and biological markers in pituitary adenomas with invasion of the cavernous sinus space
LX Pan et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour
CJ McCabe et al.
CLINICAL ENDOCRINOLOGY (2003)
Role of E-cadherin, α-, β-, and γ-catenins, and p120 (cell adhesion molecules) in prolactinoma behavior
ZR Qian et al.
MODERN PATHOLOGY (2002)
Topoisomerase IIα expression in pituitary adenomas and carcinomas:: Relationship to tumor behavior
S Vidal et al.
MODERN PATHOLOGY (2002)
分享论文
